We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCH
1976
DELISTED
Arch Resources, Inc.
ARCH
-8,029
Closed -$1.1M
ESTE
1977
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
-12,657
Closed -$160K
FBC
1978
DELISTED
Flagstar Bancorp, Inc. New
FBC
-30,001
Closed -$1.27M
ATVI
1979
DELISTED
Activision Blizzard
ATVI
-7,414
Closed -$594K
SIVB
1980
DELISTED
SVB Financial Group
SIVB
-657
Closed -$368K
LUNA
1981
DELISTED
Luna Innovations Incorporated
LUNA
-74,142
Closed -$572K
AAWW
1982
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-5,081
Closed -$439K
DOC
1983
DELISTED
PHYSICIANS REALTY TRUST
DOC
-39,884
Closed -$700K
SAFE
1984
DELISTED
Safehold Inc.
SAFE
-4,943
Closed -$274K
HR
1985
DELISTED
Healthcare Realty Trust Incorporated
HR
-12,107
Closed -$333K

Similar funds

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.